Ładuje się......
Immune Checkpoint Inhibitor‐Associated Myocarditis
Immune checkpoint inhibitors (ICIs) are approved for a wide range of malignancies. They work by priming the immune system response to cancer and have changed the landscape of available cancer treatments. As anticipated, modulation of the regulatory controls in the immune system with ICIs results in...
Zapisane w:
| Wydane w: | Oncologist |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
AlphaMed Press
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156176/ https://ncbi.nlm.nih.gov/pubmed/29802219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0130 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|